Leading BioSciences Reports Positive Interim Results from Phase 2 Trial of LB1148 in Patients Undergoing Major Surgery
19 juin 2018 07h05 HE
|
Leading BioSciences
CARLSBAD, Calif., June 19, 2018 (GLOBE NEWSWIRE) -- Leading BioSciences, a drug development company focused on improving human health through therapeutic protection of the Gastrobiome™, today...
The Human Microbiome: Advancing New Frontiers in a Rapidly Emerging Market
17 mai 2016 11h20 HE
|
Insight Pharma Reports
NEEDHAM, MA--(Marketwired - May 17, 2016) - Insight Pharma Reports, a division of Healthtech Publishing, offers additional coverages on the human microbiome with a second report, "The Human...
Newest Data on the Human Microbiome and Its Growth Into the Commercial Market
10 mai 2016 13h30 HE
|
Insight Pharma Reports
NEEDHAM, MA--(Marketwired - May 10, 2016) - Insight Pharma Reports, a division of Healthtech Publishing, offers a series of market data on the human microbiome in the form of two life science...